CGL
REGN icon

Clarius Group LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Clarius Group LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$657K Buy
851
+6
+0.7% +$4.08K 0.04% 166
2025
Q3 		$475K Sell
845
-244
-22% -$138K 0.03% 216
2025
Q2 		$572K Sell
1,089
-40
-4% -$22.3K 0.03% 228
2025
Q1 		$716K Buy
1,129
+509
+82% +$350K 0.05% 191
2024
Q4 		$442K Sell
620
-21
-3% -$17.6K 0.03% 244
2024
Q3 		$673K Sell
641
-16
-2% -$17.8K 0.05% 169
2024
Q2 		$691K Sell
657
-20
-3% -$19.4K 0.05% 169
2024
Q1 		$652K Sell
677
-105
-13% -$99.8K 0.05% 183
2023
Q4 		$687K Sell
782
-12
-2% -$9.88K 0.06% 187
2023
Q3 		$653K Sell
794
-208
-21% -$163K 0.06% 171
2023
Q2 		$720K Buy
1,002
+21
+2% +$16.2K 0.06% 197
2023
Q1 		$806K Buy
981
+32
+3% +$24.1K 0.07% 160
2022
Q4 		$685K Buy
949
+117
+14% +$86.3K 0.06% 183
2022
Q3 		$573K Hold
832
– – 0.06% 195
2022
Q2 		$492K Buy
832
+42
+5% +$27.3K 0.05% 217
2022
Q1 		$499K Hold
790
– – 0.04% 241
2021
Q4 		$499K Buy
790
+83
+12% +$51K 0.04% 241
2021
Q3 		$428K Buy
707
+44
+7% +$27.3K 0.04% 248
2021
Q2 		$370K Sell
663
-4
-0.6% -$2.03K 0.03% 269
2021
Q1 		$316K Buy
667
+52
+8% +$25.3K 0.03% 281
2020
Q4 		$297K Buy
615
+60
+11% +$32.4K 0.03% 263
2020
Q3 		$311K Sell
555
-102
-16% -$61.8K 0.04% 207
2020
Q2 		$410K Buy
+657
New +$373K 0.06% 171

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Clarius Group LLC's REGN Position: Q4 2025 in Review

Clarius Group LLC increased its Regeneron Pharmaceuticals (REGN) stake by 0.71% in Q4 2025, buying an estimated $4.08K and bringing the position to 851 shares worth $657K. The position accounts for 0.04% of the portfolio, ranked #166.

Clarius Group LLC first reported a position in REGN in Q2 2020 and has held it in 23 quarters since. The position peaked at $806K in Q1 2023. 1,386 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Clarius Group LLC held 851 shares of Regeneron Pharmaceuticals worth $657K as of Q4 2025.
  • Clarius Group LLC bought 6 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $4.08K.
  • Regeneron Pharmaceuticals made up 0.04% of Clarius Group LLC's portfolio in Q4 2025, its #166 holding.
  • Clarius Group LLC first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 23 quarters since.
  • Clarius Group LLC's Regeneron Pharmaceuticals position peaked at $806K in Q1 2023.
  • 1,386 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.